Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New Zealand Richard J. MilneStephen Vander Hoorn Original Research Article 06 August 2012 Pages: 281 - 300
Global spending on orphan drugs in France, Germany, the UK, Italy and Spain during 2007 Javier OrofinoJavier SotoItziar Oyagüez Original Research Article 06 August 2012 Pages: 301 - 315
Cost of illness and drivers of cost in atrial fibrillation in Sweden and Germany Linus JönssonÅsa EliassonNils Edvardsson Original Research Article 06 August 2012 Pages: 317 - 325
Cost effectiveness of long-acting risperidone in Sweden Marja HensenBart HeegBen van Hout Original Research Article 06 August 2012 Pages: 327 - 341
Issues surrounding orphan disease and orphan drug policies in Europe Alain DenisLut MergaertSteven Simoens Current Opinion 06 August 2012 Pages: 343 - 350
Economic efficiency of alcohol policy Christopher M. DoranThameemul A. Jainullabudeen Editorial Open access 06 August 2012 Pages: 351 - 354